Pneumococcal Vaccine Industry Research Report 2024
Summary
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, the global Pneumococcal Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine.
The report will help the Pneumococcal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Pneumococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pneumococcal Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pneumococcal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, the global Pneumococcal Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine.
The report will help the Pneumococcal Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Pneumococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
- PPSV 23
- PCV 7/13
- PCV 10
- Child
- Adult
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pneumococcal Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pneumococcal Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pneumococcal Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Pneumococcal Vaccine Sales (2019-2030)
2.2.3 Global Pneumococcal Vaccine Market Average Price (2019-2030)
2.3 Pneumococcal Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 PPSV
2.3.3 PCV 7/13
2.3.4 PCV
2.4 Pneumococcal Vaccine by End User
2.4.1 Market Value Comparison by End User (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Child
2.4.3 Adult
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Pneumococcal Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Pneumococcal Vaccine Sales (K Doses) of Manufacturers (2019-2024)
3.3 Global Pneumococcal Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Pneumococcal Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Pneumococcal Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pneumococcal Vaccine, Product Type & Application
3.8 Global Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
3.9 Global Pneumococcal Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Pfizer
4.1.1 Pfizer Company Information
4.1.2 Pfizer Business Overview
4.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
4.1.5 Pfizer Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Pneumococcal Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 MSD
4.3.1 MSD Company Information
4.3.2 MSD Business Overview
4.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 MSD Pneumococcal Vaccine Product Portfolio
4.3.5 MSD Recent Developments
4.4 Sanofipasteur
4.4.1 Sanofipasteur Company Information
4.4.2 Sanofipasteur Business Overview
4.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
4.4.5 Sanofipasteur Recent Developments
4.5 CDIBP
4.5.1 CDIBP Company Information
4.5.2 CDIBP Business Overview
4.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
4.5.5 CDIBP Recent Developments
5 GLOBAL PNEUMOCOCCAL VACCINE MARKET SCENARIO BY REGION
5.1 Global Pneumococcal Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Pneumococcal Vaccine Sales by Region: 2019-2030
5.2.1 Global Pneumococcal Vaccine Sales by Region: 2019-2024
5.2.2 Global Pneumococcal Vaccine Sales by Region: 2025-2030
5.3 Global Pneumococcal Vaccine Revenue by Region: 2019-2030
5.3.1 Global Pneumococcal Vaccine Revenue by Region: 2019-2024
5.3.2 Global Pneumococcal Vaccine Revenue by Region: 2025-2030
5.4 North America Pneumococcal Vaccine Market Facts & Figures by Country
5.4.1 North America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Pneumococcal Vaccine Sales by Country (2019-2030)
5.4.3 North America Pneumococcal Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Pneumococcal Vaccine Market Facts & Figures by Country
5.5.1 Europe Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Pneumococcal Vaccine Sales by Country (2019-2030)
5.5.3 Europe Pneumococcal Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pneumococcal Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Pneumococcal Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Pneumococcal Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pneumococcal Vaccine Market Facts & Figures by Country
5.7.1 Latin America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Pneumococcal Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Pneumococcal Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pneumococcal Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Pneumococcal Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Pneumococcal Vaccine Sales by Type (2019-2030)
6.1.1 Global Pneumococcal Vaccine Sales by Type (2019-2030) & (K Doses)
6.1.2 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Pneumococcal Vaccine Revenue by Type (2019-2030)
6.2.1 Global Pneumococcal Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Pneumococcal Vaccine Price by Type (2019-2030)
7 SEGMENT BY END USER
7.1 Global Pneumococcal Vaccine Sales by End User (2019-2030)
7.1.1 Global Pneumococcal Vaccine Sales by End User (2019-2030) & (K Doses)
7.1.2 Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
7.2 Global Pneumococcal Vaccine Revenue by End User (2019-2030)
7.2.1 Global Pneumococcal Vaccine Sales by End User (2019-2030) & (US$ Million)
7.2.2 Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
7.3 Global Pneumococcal Vaccine Price by End User (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Pneumococcal Vaccine Value Chain Analysis
8.1.1 Pneumococcal Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pneumococcal Vaccine Production Mode & Process
8.2 Pneumococcal Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pneumococcal Vaccine Distributors
8.2.3 Pneumococcal Vaccine Customers
9 GLOBAL PNEUMOCOCCAL VACCINE ANALYZING MARKET DYNAMICS
9.1 Pneumococcal Vaccine Industry Trends
9.2 Pneumococcal Vaccine Industry Drivers
9.3 Pneumococcal Vaccine Industry Opportunities and Challenges
9.4 Pneumococcal Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pneumococcal Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Pneumococcal Vaccine Sales (2019-2030)
2.2.3 Global Pneumococcal Vaccine Market Average Price (2019-2030)
2.3 Pneumococcal Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 PPSV
2.3.3 PCV 7/13
2.3.4 PCV
2.4 Pneumococcal Vaccine by End User
2.4.1 Market Value Comparison by End User (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Child
2.4.3 Adult
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Pneumococcal Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Pneumococcal Vaccine Sales (K Doses) of Manufacturers (2019-2024)
3.3 Global Pneumococcal Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Pneumococcal Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Pneumococcal Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pneumococcal Vaccine, Product Type & Application
3.8 Global Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
3.9 Global Pneumococcal Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Pfizer
4.1.1 Pfizer Company Information
4.1.2 Pfizer Business Overview
4.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
4.1.5 Pfizer Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Pneumococcal Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 MSD
4.3.1 MSD Company Information
4.3.2 MSD Business Overview
4.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 MSD Pneumococcal Vaccine Product Portfolio
4.3.5 MSD Recent Developments
4.4 Sanofipasteur
4.4.1 Sanofipasteur Company Information
4.4.2 Sanofipasteur Business Overview
4.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
4.4.5 Sanofipasteur Recent Developments
4.5 CDIBP
4.5.1 CDIBP Company Information
4.5.2 CDIBP Business Overview
4.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
4.5.5 CDIBP Recent Developments
5 GLOBAL PNEUMOCOCCAL VACCINE MARKET SCENARIO BY REGION
5.1 Global Pneumococcal Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Pneumococcal Vaccine Sales by Region: 2019-2030
5.2.1 Global Pneumococcal Vaccine Sales by Region: 2019-2024
5.2.2 Global Pneumococcal Vaccine Sales by Region: 2025-2030
5.3 Global Pneumococcal Vaccine Revenue by Region: 2019-2030
5.3.1 Global Pneumococcal Vaccine Revenue by Region: 2019-2024
5.3.2 Global Pneumococcal Vaccine Revenue by Region: 2025-2030
5.4 North America Pneumococcal Vaccine Market Facts & Figures by Country
5.4.1 North America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Pneumococcal Vaccine Sales by Country (2019-2030)
5.4.3 North America Pneumococcal Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Pneumococcal Vaccine Market Facts & Figures by Country
5.5.1 Europe Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Pneumococcal Vaccine Sales by Country (2019-2030)
5.5.3 Europe Pneumococcal Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pneumococcal Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Pneumococcal Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Pneumococcal Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pneumococcal Vaccine Market Facts & Figures by Country
5.7.1 Latin America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Pneumococcal Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Pneumococcal Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pneumococcal Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Pneumococcal Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Pneumococcal Vaccine Sales by Type (2019-2030)
6.1.1 Global Pneumococcal Vaccine Sales by Type (2019-2030) & (K Doses)
6.1.2 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Pneumococcal Vaccine Revenue by Type (2019-2030)
6.2.1 Global Pneumococcal Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Pneumococcal Vaccine Price by Type (2019-2030)
7 SEGMENT BY END USER
7.1 Global Pneumococcal Vaccine Sales by End User (2019-2030)
7.1.1 Global Pneumococcal Vaccine Sales by End User (2019-2030) & (K Doses)
7.1.2 Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
7.2 Global Pneumococcal Vaccine Revenue by End User (2019-2030)
7.2.1 Global Pneumococcal Vaccine Sales by End User (2019-2030) & (US$ Million)
7.2.2 Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
7.3 Global Pneumococcal Vaccine Price by End User (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Pneumococcal Vaccine Value Chain Analysis
8.1.1 Pneumococcal Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pneumococcal Vaccine Production Mode & Process
8.2 Pneumococcal Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pneumococcal Vaccine Distributors
8.2.3 Pneumococcal Vaccine Customers
9 GLOBAL PNEUMOCOCCAL VACCINE ANALYZING MARKET DYNAMICS
9.1 Pneumococcal Vaccine Industry Trends
9.2 Pneumococcal Vaccine Industry Drivers
9.3 Pneumococcal Vaccine Industry Opportunities and Challenges
9.4 Pneumococcal Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by End User (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pneumococcal Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Pneumococcal Vaccine Sales (K Doses) of Manufacturers (2018-2023)
Table 7. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Pneumococcal Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Pneumococcal Vaccine Average Price (USD/Dose) of Manufacturers (2018-2023)
Table 11. Global Pneumococcal Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Pneumococcal Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Pfizer Company Information
Table 17. Pfizer Business Overview
Table 18. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 19. Pfizer Pneumococcal Vaccine Product Portfolio
Table 20. Pfizer Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 24. GSK Pneumococcal Vaccine Product Portfolio
Table 25. GSK Recent Developments
Table 26. MSD Company Information
Table 27. MSD Business Overview
Table 28. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 29. MSD Pneumococcal Vaccine Product Portfolio
Table 30. MSD Recent Developments
Table 31. Sanofipasteur Company Information
Table 32. Sanofipasteur Business Overview
Table 33. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 34. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 35. Sanofipasteur Recent Developments
Table 36. CDIBP Company Information
Table 37. CDIBP Business Overview
Table 38. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 39. CDIBP Pneumococcal Vaccine Product Portfolio
Table 40. CDIBP Recent Developments
Table 41. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Global Pneumococcal Vaccine Sales by Region (2018-2023) & (K Doses)
Table 43. Global Pneumococcal Vaccine Sales Market Share by Region (2018-2023)
Table 44. Global Pneumococcal Vaccine Sales by Region (2024-2029) & (K Doses)
Table 45. Global Pneumococcal Vaccine Sales Market Share by Region (2024-2029)
Table 46. Global Pneumococcal Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 47. Global Pneumococcal Vaccine Revenue Market Share by Region (2018-2023)
Table 48. Global Pneumococcal Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 49. Global Pneumococcal Vaccine Revenue Market Share by Region (2024-2029)
Table 50. North America Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. North America Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 52. North America Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 53. North America Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 54. North America Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 55. Europe Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. Europe Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 57. Europe Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 58. Europe Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 59. Europe Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 60. Asia Pacific Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. Asia Pacific Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 62. Asia Pacific Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 63. Asia Pacific Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 64. Asia Pacific Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 65. Latin America Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Latin America Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 67. Latin America Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 68. Latin America Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 69. Latin America Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 70. Middle East and Africa Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Middle East and Africa Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 72. Middle East and Africa Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 73. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 74. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 75. Global Pneumococcal Vaccine Sales by Type (2018-2023) & (K Doses)
Table 76. Global Pneumococcal Vaccine Sales by Type (2024-2029) & (K Doses)
Table 77. Global Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Table 78. Global Pneumococcal Vaccine Sales Market Share by Type (2024-2029)
Table 79. Global Pneumococcal Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 80. Global Pneumococcal Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 81. Global Pneumococcal Vaccine Revenue Market Share by Type (2018-2023)
Table 82. Global Pneumococcal Vaccine Revenue Market Share by Type (2024-2029)
Table 83. Global Pneumococcal Vaccine Price by Type (2018-2023) & (USD/Dose)
Table 84. Global Pneumococcal Vaccine Price by Type (2024-2029) & (USD/Dose)
Table 85. Global Pneumococcal Vaccine Sales by End User (2018-2023) & (K Doses)
Table 86. Global Pneumococcal Vaccine Sales by End User (2024-2029) & (K Doses)
Table 87. Global Pneumococcal Vaccine Sales Market Share by End User (2018-2023)
Table 88. Global Pneumococcal Vaccine Sales Market Share by End User (2024-2029)
Table 89. Global Pneumococcal Vaccine Revenue by End User (2018-2023) & (US$ Million)
Table 90. Global Pneumococcal Vaccine Revenue by End User (2024-2029) & (US$ Million)
Table 91. Global Pneumococcal Vaccine Revenue Market Share by End User (2018-2023)
Table 92. Global Pneumococcal Vaccine Revenue Market Share by End User (2024-2029)
Table 93. Global Pneumococcal Vaccine Price by End User (2018-2023) & (USD/Dose)
Table 94. Global Pneumococcal Vaccine Price by End User (2024-2029) & (USD/Dose)
Table 95. Key Raw Materials
Table 96. Raw Materials Key Suppliers
Table 97. Pneumococcal Vaccine Distributors List
Table 98. Pneumococcal Vaccine Customers List
Table 99. Pneumococcal Vaccine Industry Trends
Table 100. Pneumococcal Vaccine Industry Drivers
Table 101. Pneumococcal Vaccine Industry Restraints
Table 102. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by End User (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pneumococcal Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Pneumococcal Vaccine Sales (K Doses) of Manufacturers (2018-2023)
Table 7. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Pneumococcal Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Pneumococcal Vaccine Average Price (USD/Dose) of Manufacturers (2018-2023)
Table 11. Global Pneumococcal Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Pneumococcal Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Pfizer Company Information
Table 17. Pfizer Business Overview
Table 18. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 19. Pfizer Pneumococcal Vaccine Product Portfolio
Table 20. Pfizer Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 24. GSK Pneumococcal Vaccine Product Portfolio
Table 25. GSK Recent Developments
Table 26. MSD Company Information
Table 27. MSD Business Overview
Table 28. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 29. MSD Pneumococcal Vaccine Product Portfolio
Table 30. MSD Recent Developments
Table 31. Sanofipasteur Company Information
Table 32. Sanofipasteur Business Overview
Table 33. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 34. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 35. Sanofipasteur Recent Developments
Table 36. CDIBP Company Information
Table 37. CDIBP Business Overview
Table 38. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 39. CDIBP Pneumococcal Vaccine Product Portfolio
Table 40. CDIBP Recent Developments
Table 41. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Global Pneumococcal Vaccine Sales by Region (2018-2023) & (K Doses)
Table 43. Global Pneumococcal Vaccine Sales Market Share by Region (2018-2023)
Table 44. Global Pneumococcal Vaccine Sales by Region (2024-2029) & (K Doses)
Table 45. Global Pneumococcal Vaccine Sales Market Share by Region (2024-2029)
Table 46. Global Pneumococcal Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 47. Global Pneumococcal Vaccine Revenue Market Share by Region (2018-2023)
Table 48. Global Pneumococcal Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 49. Global Pneumococcal Vaccine Revenue Market Share by Region (2024-2029)
Table 50. North America Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. North America Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 52. North America Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 53. North America Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 54. North America Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 55. Europe Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. Europe Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 57. Europe Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 58. Europe Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 59. Europe Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 60. Asia Pacific Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. Asia Pacific Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 62. Asia Pacific Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 63. Asia Pacific Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 64. Asia Pacific Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 65. Latin America Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Latin America Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 67. Latin America Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 68. Latin America Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 69. Latin America Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 70. Middle East and Africa Pneumococcal Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Middle East and Africa Pneumococcal Vaccine Sales by Country (2018-2023) & (K Doses)
Table 72. Middle East and Africa Pneumococcal Vaccine Sales by Country (2024-2029) & (K Doses)
Table 73. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 74. Middle East and Africa Pneumococcal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 75. Global Pneumococcal Vaccine Sales by Type (2018-2023) & (K Doses)
Table 76. Global Pneumococcal Vaccine Sales by Type (2024-2029) & (K Doses)
Table 77. Global Pneumococcal Vaccine Sales Market Share by Type (2018-2023)
Table 78. Global Pneumococcal Vaccine Sales Market Share by Type (2024-2029)
Table 79. Global Pneumococcal Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 80. Global Pneumococcal Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 81. Global Pneumococcal Vaccine Revenue Market Share by Type (2018-2023)
Table 82. Global Pneumococcal Vaccine Revenue Market Share by Type (2024-2029)
Table 83. Global Pneumococcal Vaccine Price by Type (2018-2023) & (USD/Dose)
Table 84. Global Pneumococcal Vaccine Price by Type (2024-2029) & (USD/Dose)
Table 85. Global Pneumococcal Vaccine Sales by End User (2018-2023) & (K Doses)
Table 86. Global Pneumococcal Vaccine Sales by End User (2024-2029) & (K Doses)
Table 87. Global Pneumococcal Vaccine Sales Market Share by End User (2018-2023)
Table 88. Global Pneumococcal Vaccine Sales Market Share by End User (2024-2029)
Table 89. Global Pneumococcal Vaccine Revenue by End User (2018-2023) & (US$ Million)
Table 90. Global Pneumococcal Vaccine Revenue by End User (2024-2029) & (US$ Million)
Table 91. Global Pneumococcal Vaccine Revenue Market Share by End User (2018-2023)
Table 92. Global Pneumococcal Vaccine Revenue Market Share by End User (2024-2029)
Table 93. Global Pneumococcal Vaccine Price by End User (2018-2023) & (USD/Dose)
Table 94. Global Pneumococcal Vaccine Price by End User (2024-2029) & (USD/Dose)
Table 95. Key Raw Materials
Table 96. Raw Materials Key Suppliers
Table 97. Pneumococcal Vaccine Distributors List
Table 98. Pneumococcal Vaccine Customers List
Table 99. Pneumococcal Vaccine Industry Trends
Table 100. Pneumococcal Vaccine Industry Drivers
Table 101. Pneumococcal Vaccine Industry Restraints
Table 102. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pneumococcal VaccineProduct Picture
Figure 5. Global Pneumococcal Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Pneumococcal Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Pneumococcal Vaccine Sales (2018-2029) & (K Doses)
Figure 8. Global Pneumococcal Vaccine Average Price (USD/Dose) & (2018-2029)
Figure 9. PPSV 23 Product Picture
Figure 10. PCV 7/13 Product Picture
Figure 11. PCV 10 Product Picture
Figure 12. Child Product Picture
Figure 13. Adult Product Picture
Figure 14. Global Pneumococcal Vaccine Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Pneumococcal Vaccine Sales by Region in 2022
Figure 21. Global Pneumococcal Vaccine Revenue by Region in 2022
Figure 22. North America Pneumococcal Vaccine Market Size by Country in 2022
Figure 23. North America Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 24. North America Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Pneumococcal Vaccine Market Size by Country in 2022
Figure 28. Europe Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 29. Europe Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 30. Germany Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Pneumococcal Vaccine Market Size by Country in 2022
Figure 36. Asia Pacific Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 38. China Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Pneumococcal Vaccine Market Size by Country in 2022
Figure 48. Latin America Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Latin America Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Pneumococcal Vaccine Market Size by Country in 2022
Figure 54. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Pneumococcal Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Global Pneumococcal Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2018-2029)
Figure 62. Global Pneumococcal Vaccine Sales Market Share by End User (2018-2029)
Figure 63. Global Pneumococcal Vaccine Revenue Market Share by End User (2018-2029)
Figure 64. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2018-2029)
Figure 65. Pneumococcal Vaccine Value Chain
Figure 66. Pneumococcal Vaccine Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Pneumococcal Vaccine Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pneumococcal VaccineProduct Picture
Figure 5. Global Pneumococcal Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Pneumococcal Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Pneumococcal Vaccine Sales (2018-2029) & (K Doses)
Figure 8. Global Pneumococcal Vaccine Average Price (USD/Dose) & (2018-2029)
Figure 9. PPSV 23 Product Picture
Figure 10. PCV 7/13 Product Picture
Figure 11. PCV 10 Product Picture
Figure 12. Child Product Picture
Figure 13. Adult Product Picture
Figure 14. Global Pneumococcal Vaccine Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Pneumococcal Vaccine Sales by Region in 2022
Figure 21. Global Pneumococcal Vaccine Revenue by Region in 2022
Figure 22. North America Pneumococcal Vaccine Market Size by Country in 2022
Figure 23. North America Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 24. North America Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Pneumococcal Vaccine Market Size by Country in 2022
Figure 28. Europe Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 29. Europe Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 30. Germany Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Pneumococcal Vaccine Market Size by Country in 2022
Figure 36. Asia Pacific Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 38. China Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Pneumococcal Vaccine Market Size by Country in 2022
Figure 48. Latin America Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Latin America Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Pneumococcal Vaccine Market Size by Country in 2022
Figure 54. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Pneumococcal Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Pneumococcal Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Global Pneumococcal Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2018-2029)
Figure 62. Global Pneumococcal Vaccine Sales Market Share by End User (2018-2029)
Figure 63. Global Pneumococcal Vaccine Revenue Market Share by End User (2018-2029)
Figure 64. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2018-2029)
Figure 65. Pneumococcal Vaccine Value Chain
Figure 66. Pneumococcal Vaccine Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Pneumococcal Vaccine Industry Opportunities and Challenges
